Analytical True Positives in Workplace Drugs Testings Due to Use of Prescription and OTC Medications
Reference28 articles.
1. Manchikanti L. National drug control policy and prescription drug abuse: facts and fallacies. Pain Physician 2007; 10: 399–424.
2. Manchikanti L, Singh A. Therapeutic opioids: a ten year perspective on the complexities and complications of the escalating use, abuse, and nonmedical use of opioids. Pain Physician 2008; 11(2 Suppl): S63–S88.
3. Wunsch MJ, Nakamoto K, Behonick G, Massello W. Opioid deaths in rural Virginia: a description of the high prevalence of accidental fatalities involving prescribed medications. Am J Addict 2009; 18: 5–14.
4. DeRienz RT, Holler JM, Manos ME, Jemionek J et al. Evaluation of four immunoassays screening kits for the detection of benzodiazepines in urine. J Anal Toxicol 2008; 32: 433–437.
5. Klette KL, Wiegand RF, Horn CK, Stout PR et al. Urine benzodiazepine screening using Roche Online KIMS immunoassay with beta-glucuronidase hydrolysis and confirmation by gas chromatography-mass spectrometry. J Anal Toxicol 2005; 19: 193–200.